« Previous
Lung Cancer
Volume 69, Issue 2
, Pages 249-250
, August 2010
Pemetrexed-induced edema of the eyelid
References
- Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol. 2004;22(9):1589–1597
- . FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancer. Oncologist. 2005;10(6):363–368
- . Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer. Ann Oncol. 2002;13(5):737–741
- . Pemetrexed-associated urticarial vasculitis. Lung Cancer. 2006;51(2):247–249
- Severe cutaneous toxicity after pemetrexed as second line treatment for a refractory non small cell lung cancer. Rev Mal Respir. 2007;24(5):635–638
- . Pemetrexed-induced edema of the eyelid. Lung Cancer. 2006;54(2):241–242
- Severe periorbital edema secondary to STI571 (Gleevec). Cancer. 2002;95(4):881–887
- . Palpebral edema secondary to treatment by a specific inhibitor of tyrosine kinase: Glivec. A case report. J Fr Ophtalmol. 2004;27(1):107–109
- Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 2001;61(7):2929–2934
PII: S0169-5002(10)00212-6
doi: 10.1016/j.lungcan.2010.04.024
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Lung Cancer
Volume 69, Issue 2
, Pages 249-250
, August 2010
